| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/15/2003 | EP0939619B1 Detergent cosmetic compositions and use thereof |
| 01/15/2003 | EP0937057B1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 01/15/2003 | EP0925287B1 Heterocyclic metalloprotease inhibitors |
| 01/15/2003 | EP0912572B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/15/2003 | EP0907643B1 Compounds with growth hormone releasing properties |
| 01/15/2003 | EP0893987B1 Sunscreen composition comprising a solid elastomeric organopolysiloxane |
| 01/15/2003 | EP0889031B1 Simple process for producing high-quality captopril |
| 01/15/2003 | EP0880541B1 Derivatives of antibiotic ge2270 factors |
| 01/15/2003 | EP0851756B1 Use of ondansetron in the manufacture of a medicament for the treatment of tremor |
| 01/15/2003 | EP0834314B1 Granules containing pranlukast, process for producing the granules, and method of lowering cohesiveness of pranlukast |
| 01/15/2003 | EP0820451B1 Novel heterocyclic compounds |
| 01/15/2003 | EP0817636B1 Cinnamoyl-c-glycoside chromone isolated from aloe barbadensis |
| 01/15/2003 | EP0790988B1 Use of dioxomorpholines to combat endoparasites, novel dioxomorpholines and process for their production |
| 01/15/2003 | EP0787723B1 Cyclopropachromenecarboxylate derivatives |
| 01/15/2003 | EP0778767B1 Delivery of solid drug compositions |
| 01/15/2003 | EP0769949B1 Hydromorphone therapy |
| 01/15/2003 | EP0751769B1 Medical treatment using thyroid hormones |
| 01/15/2003 | EP0730444B1 Sustained release formulations for 24 hour release of metoprolol |
| 01/15/2003 | EP0729468B1 Non-peptide tachykinin receptor antagonists |
| 01/15/2003 | EP0722442B1 Polyazacycloalkanes as dichelants |
| 01/15/2003 | EP0713483B1 Amidine derivatives with nitric oxide synthetase activities |
| 01/15/2003 | EP0659078B1 Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system |
| 01/15/2003 | EP0649412B1 Pharmaceutical pyridine compounds |
| 01/15/2003 | EP0595796B1 Method of treatment of androgen-related diseases |
| 01/15/2003 | EP0584347B1 Enantiomeric hydroxylated xanthine compounds |
| 01/15/2003 | CN1391608A Cloning, expression and characterisation of gene expressed in tumour cells and involved in regulation of immune response |
| 01/15/2003 | CN1391578A B-D-5-thioxylose derivatives, preparation method and therapeutic use |
| 01/15/2003 | CN1391577A Pharmaceutical compositions comprising metal complexes |
| 01/15/2003 | CN1391576A Androgen receptor modulator compounds and methods |
| 01/15/2003 | CN1391575A Nitrogen containing heterobicycles as factor XA inhibitors |
| 01/15/2003 | CN1391574A Pyrazolo[1,5-d][1,2,4] triazines for enhancing cognition |
| 01/15/2003 | CN1391573A Bicyclic imidazo-3-yl-amine derivatives |
| 01/15/2003 | CN1391572A Oxazolidinones having sulfoximine functionality and their use as antimicrobial agents |
| 01/15/2003 | CN1391571A Heterocyclic compounds and their use as medicines |
| 01/15/2003 | CN1391570A Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
| 01/15/2003 | CN1391564A Chemical compounds |
| 01/15/2003 | CN1391563A Therapeutic quinazoline derivatives |
| 01/15/2003 | CN1391562A Quinazoline derivatives as pharmaceuticals |
| 01/15/2003 | CN1391561A Quinazoline compounds and pharmaceutical compositions containing them |
| 01/15/2003 | CN1391560A 喹唑啉衍生物 Quinazoline derivatives |
| 01/15/2003 | CN1391558A Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 01/15/2003 | CN1391557A 6-position substituted indoline, production and use thereof as medicament |
| 01/15/2003 | CN1391556A IL-8 receptor antagonists |
| 01/15/2003 | CN1391555A Benzamides and related inhibitors of factor Xa |
| 01/15/2003 | CN1391487A Methods for treating therapy-resistant tumors |
| 01/15/2003 | CN1391486A Methods for treating therapy-resistant tumors |
| 01/15/2003 | CN1391485A Particulate vitamin composition |
| 01/15/2003 | CN1391484A Method of potentiating chemotherapy and treating solid tumors |
| 01/15/2003 | CN1391482A Therapy |
| 01/15/2003 | CN1391479A Medicament for inducing tolerance |
| 01/15/2003 | CN1391477A Physical strength enhancing agents and glycogen accumulation promoting agents |
| 01/15/2003 | CN1391476A Vasopressin agonist formulation and process |
| 01/15/2003 | CN1391475A Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 01/15/2003 | CN1391474A 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 01/15/2003 | CN1391473A VLA-4 inhibitor compounds |
| 01/15/2003 | CN1391472A Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases |
| 01/15/2003 | CN1391471A Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 01/15/2003 | CN1391470A Pharmaceutical composition and method for treatment of inflammation |
| 01/15/2003 | CN1391469A Npyy5拮抗剂 Npyy5 antagonist |
| 01/15/2003 | CN1391468A Pharmaceutical compositions comprising adenosine receptor agonist or antagonist |
| 01/15/2003 | CN1391467A Method of microencapsulation |
| 01/15/2003 | CN1391466A Vasopressin antagonist formulation and process |
| 01/15/2003 | CN1391465A 包衣 Coating |
| 01/15/2003 | CN1391464A Formulation for menopausal women |
| 01/15/2003 | CN1390846A Aminoglycopeptide compounds with antivirus and anticanser activity |
| 01/15/2003 | CN1390839A Composition of garcinolic acid compounds, its preparing process and medical composition using it as active component |
| 01/15/2003 | CN1390837A Anti-inflammatory and antineoplastic R-bis or glycophenylpropane isoselenazole substituted compound |
| 01/15/2003 | CN1390836A Optical antimer of Saikexiaozuo and its preparing process and usage |
| 01/15/2003 | CN1390834A Indenoindolone compounds, their preparation and medicinal compositions containing them |
| 01/15/2003 | CN1390832A N,N'-diacetylcystine-arginine salt and its preparing process and usage |
| 01/15/2003 | CN1390605A Medicine C-AEDP using C as carrier for target therapy of osteopath and its usage |
| 01/15/2003 | CN1390599A Prescription of lotion for treating pile and fistula and its preapring process |
| 01/15/2003 | CN1390593A Chinese-medicinal ointment for treating burn |
| 01/15/2003 | CN1390589A Quick-acting antalgesic-antipruritic tincture |
| 01/15/2003 | CN1390585A Chinese medicine for detoxication purpose and its preparing process |
| 01/15/2003 | CN1390576A Exterior-applied medicine for treating rhinitis and nasosinusitis |
| 01/15/2003 | CN1390571A Chinese medicine for treating burn and scald |
| 01/15/2003 | CN1390564A Medicine for treating digestive ulcer |
| 01/15/2003 | CN1390562A Chinese medicine for treating burn and scald and its preparing process |
| 01/15/2003 | CN1390551A Pharmaceutical usage of diosgenin |
| 01/15/2003 | CN1390550A Freeze-dried minocycline hydrochloride powder injection and its preparing process |
| 01/15/2003 | CN1390549A Medicine for treating beriberi |
| 01/15/2003 | CN1390548A Antipruritic liquid |
| 01/15/2003 | CN1390547A Therapy for tissue damage by local ischemia |
| 01/15/2003 | CN1390546A Prescription of compound rifampin |
| 01/15/2003 | CN1390545A Prescription and preparing process of dispamil injection |
| 01/15/2003 | CN1390544A Antineoplastic usage of iodated-3,3'-diethyl-9-methyl thiocarbonyl cyanine |
| 01/15/2003 | CN1390543A Oxiracetam injection |
| 01/15/2003 | CN1390542A Freeze-dried ginkgolide powder injection and its preparing process |
| 01/15/2003 | CN1390541A Naofusu |
| 01/15/2003 | CN1390540A Preparing process and usage of zine taurinate |
| 01/15/2003 | CN1390539A Freeze-dried tranexamine powder injection and its preparing prcess |
| 01/15/2003 | CN1390538A Slow-releasing Wannailuowei hydrochloride tablet and its preparing process |
| 01/15/2003 | CN1390537A Medicine for preventing or treating cancer and its usage |
| 01/15/2003 | CN1390534A Composition containing semicrystalized polymer gelled liquid fatty phase |
| 01/15/2003 | CN1098851C New ellipticine achroalkali compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/15/2003 | CN1098849C 噻唑衍生物 Thiazole derivatives |
| 01/15/2003 | CN1098848C Acids and esters of diosmetin and pharmaceutical compositions containing them |
| 01/15/2003 | CN1098847C Furan-and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of replication of HIV-1 and HIV-1 mutants |